Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

14
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
14
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

15
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
15
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

16
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
16
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

13
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
13
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

46
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
46
Factors Influencing Bioavailability: First-Pass Elimination01:23

Factors Influencing Bioavailability: First-Pass Elimination

7.2K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4.

Apoptosis : an international journal on programmed cell death·2026
Same author

Colorimetric Quantification of Dopamine as a Bioactive Compound in Banana Peel Extracts: A Sustainable Approach to Food Waste Valorization.

ACS omega·2026
Same author

Integrated structure-based and fragment-guided design of isonicotinic acid derivatives as potential KDM4A inhibitors: an in silico study.

Journal of computer-aided molecular design·2026
Same author

Thiourea-Based H<sub>2</sub>S-Releasing Pramipexole Hybrids as Neuroprotective Agents.

Antioxidants (Basel, Switzerland)·2026
Same author

Isothiocyanates as Ferroptosis Inducers to Promote Cancer Cell Death.

Phytotherapy research : PTR·2026
Same author

In Vitro and Ex Vivo Evaluation of a Multi-Target Combination of Plant Extracts and Policosanols: Effects in Mitigating Heart Inflammation and Oxidative Stress.

Foods (Basel, Switzerland)·2026

Related Experiment Video

Updated: Oct 15, 2025

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
09:50

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin

Published on: December 22, 2023

1.9K

Improving Curcumin Bioavailability: Current Strategies and Future Perspectives.

Rita Tabanelli1, Simone Brogi1, Vincenzo Calderone1

  • 1Department of Pharmacy, University of Pisa, Via Bonanno 6, I-56126 Pisa, Italy.

Pharmaceutics
|October 23, 2021
PubMed
Summary
This summary is machine-generated.

Curcumin

Keywords:
bioavailabilitycurcumindelivery by designdelivery methodsnanoparticles

More Related Videos

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.1K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
09:50

Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin

Published on: December 22, 2023

1.9K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.1K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.1K

Area of Science:

  • Pharmacology
  • Drug Delivery
  • Nanotechnology

Background:

  • Curcumin exhibits significant pharmacological potential.
  • Its therapeutic use is limited by poor bioavailability due to low absorption, rapid metabolism, and quick clearance.
  • Addressing these delivery challenges is crucial for unlocking curcumin's benefits.

Purpose of the Study:

  • To review and analyze advanced strategies for enhancing curcumin bioavailability.
  • To evaluate the efficacy of various curcumin delivery systems in clinical trials.
  • To explore future perspectives for effective curcumin formulations.

Main Methods:

  • Literature review of current and emerging curcumin delivery technologies.
  • Analysis of strategies including adjuvants, complexation, encapsulation, and nanoparticle formulations.
  • Examination of clinical trial data on the efficacy of improved curcumin bioavailability.

Main Results:

  • Improved curcumin bioavailability correlates with enhanced therapeutic efficacy in clinical studies.
  • Nanoparticle-based delivery systems show significant promise for effective curcumin formulations.
  • Various strategies like encapsulation and specific formulations are being developed to overcome bioavailability issues.

Conclusions:

  • Optimizing curcumin delivery is essential for its successful clinical application.
  • Advanced formulations, particularly those utilizing nanotechnology, offer a promising future for curcumin therapeutics.
  • Effective delivery methods will enable the use of curcumin as a preventive and disease-modifying agent.